Targeting cancer’s nutrient seeking protein could restrict growth
5 October 2015 | By Victoria White
Initial studies by Oxford University researchers show that targeting the protein, called PAT4, could restrict cancerous cells' ability to grow...
List view / Grid view
News
Cancer drug RGFP966 appears to sharpen memory
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
Nobel Prize recognises discoveries in parasitic diseases
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
Biogen to work with Genomics to refine drug target selection
5 October 2015 | By Victoria White
Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide drug research and development...
XOMA licenses anti-TGFb antibody programme to Novartis
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
Researchers disguise anti-cancer drugs as platelets
2 October 2015 | By Victoria White
The technique allows drugs to last longer in the body and attack both primary cancer tumours and the circulating tumour cells...
Genisphere raises $4m in funding to extend its 3DNA platform
2 October 2015 | By Victoria White
Genesphere's goal is to license the 3DNA platform to pharmaceutical partners and complete the preclinical work necessary to advance the its own lead drug candidates...
Scientists develop drug to prevent diabetic enteropathy
2 October 2015 | By Victoria White
Scientists have discovered a protein that 'soaks up' the overproduced hormone that leads to diabetic enteropathy...
1000 Genomes Project team create largest catalogue of genomic differences
2 October 2015 | By Victoria White
Understanding how genomic variants contribute to disease may help clinicians develop improved diagnostics and treatments, in addition to new methods of prevention...
Receptor identified as potential target for treatment of autism
1 October 2015 | By Victoria White
Scientists have uncovered a relationship between a chemical that helps transmit signals in the brain and genetic mutations present in a subset of individuals with autism...
Drug discovery initiative TaNeDS opens for applications
1 October 2015 | By Victoria White
The TaNeDS programme provides close partnership between successful applicants and scientists in Daiichi Sankyo to tackle unmet medical needs...
Cancer stopped in its tracks by reprogrammed fibroblasts
1 October 2015 | By Victoria White
If further studies show this route can benefit patients, it could help crack one of the toughest challenges in cancer research – how to stop tumours spreading...
FDA grants orphan drug designation to BLU-554
30 September 2015 | By Victoria White
BLU-554, an exquisitely selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), is currently being evaluated in a Phase 1 clinical trial in patients with advanced hepatocellular carcinoma...
Aspen Park acquires rights to castration resistant prostate cancer drug
30 September 2015 | By Victoria White
APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer...
UbiVac and Janssen to develop vaccine to intercept oral cancer
30 September 2015 | By Victoria White
Development of an immunotherapy that induced broad anti-cancer immunity and inhibited oral leukoplakia from transforming into oral cancer would represent a paradigm shift for treating this disease...
